← Back to Clinical Trials
Recruiting NCT06516640

Type 2 Continuous Glucose Monitoring Academy

Trial Parameters

Condition Type 2 Diabetes
Sponsor Children's Hospital Los Angeles
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 8 Years
Max Age 21 Years
Start Date 2025-06-23
Completion 2026-09-01
Interventions
Continuous Glucose Monitoring AcademyStandard Education

Brief Summary

The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D): * The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies. * The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics. * The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics. Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.

Eligibility Criteria

Inclusion Criteria: 1. Current age of 8-21 years; 2. T2D diagnosis; 3. Able to speak, read, and write English or Spanish Exclusion Criteria: a. Known history of medical adhesive allergies;

Related Trials